Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis
Obiettivi del progetto
Valutare l’impatto della dose-escalation nel trattamento dei tumori polmonari non-microcitmoa localmente avanzati
Data di inizio e fine
2014 - 2015
Responsabile del progetto
Prof.ssa Sara Ramella
Istituzione coordinatrice del progetto
London Health Sciences Centre - London, Ontario, Canada
Altre Istituzioni coinvolte nel progetto
- MAASTRO Clinic - Maastricht, The Netherlands
- VU University Medical Center - Amsterdam, The Netherlands
- Hyogo Cancer Center - Akashi, Japan
- Universidad de Navarra - Pamplona, Spain
- National Cancer Center - Goyang-si, Gy eonggi, Korea
- University of North Carolina - Chapel Hill, North Carolina
- University of Washington - Seattle, Washington
- Karolinska University Hospital - Stockholm, Sweden
- Ghent University - Ghent, Belgium
- Universidad Pompeu Fabra - Barcelona, Spain
- London Health Sciences Centre - London, Ontario, Canada
- Washington University School of Medicine - St. Louis, Missouri
